BCBA/PHG (BCBA/PHG)

Buenos Aires Stock Exchange: BCBA/PHG · ARS

ARS 8,925

+210.00 (+2.4%)· Recorded snapshot

Market cap	40.6T
Revenue (ttm)	29.9T
Net income (ttm)	1.9T
EPS (ttm)	ARS 392
P/E (trailing)	22.7x
P/E (forward)	15.0x
Dividend	ARS 274 (3.08%)
Volume	881

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 29.9T
Net income (ttm): 1.9T
EPS (ttm): ARS 392
P/E (trailing): 22.7x
P/E (forward): 15.0x
Market cap: 40.6T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 13:30 UTC

Forward P/E15

P25 n/aP50 n/aP75 n/a

Trailing P/E22.7

P25 n/aP50 n/aP75 n/a

ROE10.2

P25 n/aP50 n/aP75 n/a

ROIC7.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/PHG indicators

Market & fundamental data

Available fields

242

Groups with data

Currency

EUR

Showing 242 of 242 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	Netherlands
Country code	AR
Earnings date	2026-11-03
Employees	63,670
Employees change	-1,547
Employees growth	-2.47%
Enterprise value	ARS 50.4T
Exchange	Buenos Aires Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1891
Industry	Medical Devices
Is primary listing	No
ISIN number	ARDEUT110558
Last earnings date	2026-07-28
Last refreshed	2026-10-29
Last stock split date	2024-05-09
Last stock split type	Forward
Market cap	ARS 40.6T
Next earnings date	2026-11-03
Price	ARS 8,925.00
Price currency	ARS
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-28
Symbol	bcba/PHG
Website	https://www.philips.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	31.45x
Earnings yield	4.4%
EV/Earnings	26.72x
EV/EBIT	17.08x
EV/EBITDA	11.31x
EV/FCF	14.93x
EV/Sales	1.66x
FCF / EV yield	6.7%
FCF yield	8.31%
Forward P/E	15.01x
Graham number	6310.55139
Graham upside	-29.29%
Lynch fair value	ARS 2,072.49
Lynch upside	-76.78%
P/(FCF - SBC) ratio	12.96x
P/(OCF - SBC) ratio	11.21x
P/B ratio	2.09x
P/E ratio	22.74x
P/FCF ratio	12.03x
P/OCF ratio	10.51x
P/S ratio	1.36x
Price/EBITDA ratio	9.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	9.78%
EBITDA margin	13.68%
Effective tax rate	24.63%
FCF margin	11.13%
Gross margin	45.94%
Operating margin	9.78%
Pretax margin	8.34%
Profit margin	6.31%
Profit per employee	ARS 29.6M
Profitable quarters	6
Profitable years	1
Revenue per employee	ARS 469.6M
ROA	4.07%
ROA (5Y)	1.36%
ROCE	8.96%
ROE	10.15%
ROE (5Y)	-1.95%
ROIC	7.65%
ROIC (5Y)	-5.23%
SBC / revenue	0.81%
Tax / revenue	2.05%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	555%
EPS growth (Q)	61.35%
EPS growth (QoQ)	152.07%
EPS growth 10Y	4.58%
EPS growth 5Y	-0.44%
EPS growth quarters	3
EPS growth years	1
FCF growth	142.58%
FCF growth (Q)	-3.7%
FCF growth (QoQ)	171.3%
FCF growth 3Y	78.43%
FCF growth 5Y	-2.89%
Gross profit growth	3.67%
Gross profit growth (Q)	6.91%
Gross profit growth 3Y	1.91%
Gross profit growth 5Y	0.5%
Net income growth	587.65%
Net income growth (Q)	60%
Net income growth (QoQ)	154.3%
Net income growth 5Y	-0.3%
Net income growth quarters	4
Net income growth years	1
OCF growth	107.64%
OCF growth (Q)	-2.84%
OCF growth (QoQ)	100%
OCF growth 10Y	-2.53%
OCF growth 3Y	43.89%
OCF growth 5Y	-3.46%
Operating income growth	63.48%
Operating income growth (Q)	52.12%
Operating income growth 3Y	79.86%
Operating income growth 5Y	2.05%
Revenue growth	-1.06%
Revenue growth (Q)	0.51%
Revenue growth (QoQ)	11.65%
Revenue growth 10Y	-1.66%
Revenue growth 3Y	-1.29%
Revenue growth 5Y	-0.04%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	ARS -487.5B
Depreciation and amortization	ARS 1.2T
EBIT	ARS 2.9T
EBITDA	ARS 4.1T
EPS	ARS 392.45
Financing cash flow	ARS -2.7T
Free cash flow	ARS 3.4T
Free cash flow minus SBC	ARS 3.1T
Gross profit	ARS 13.7T
Income taxes	ARS 614.4B
Investing cash flow	ARS -1.3T
Net borrowing	ARS -2T
Net cash flow	ARS -55.9B
Net income	ARS 1.9T
Operating cash flow minus SBC	ARS 3.6T
Operating income	ARS 2.9T
Revenue	ARS 29.9T
Stock-based compensation	ARS 242B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.02
Book value per share	ARS 19,822.20
Debt / EBITDA	2.86
Debt / equity	0.65
Debt / FCF	3.74
Goodwill	ARS 16.6T
Interest coverage	6.08
Long-term assets	ARS 29.2T
Long-term liabilities	ARS 13T
Net cash (debt)	ARS -9.6T
Net cash / market cap	-23.66%
Net debt / EBITDA	2.35
Net debt / equity	0.49
Net debt / FCF	2.85
Piotroski F-Score	7
Property, plant and equipment	ARS 3.7T
Shareholders' equity	ARS 19.4T
Tangible book value	ARS -1.3T
Tangible book value per share	ARS -1,378.39
Total assets	ARS 45.2T
Total cash	ARS 3T
Total debt	ARS 12.6T
Total liabilities	ARS 25.8T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.67
Current assets	ARS 16T
Current liabilities	ARS 12.7T
Current ratio	1.26
Inventory turnover	2.96
Net working capital	ARS 2.1T
Quick ratio	0.73
Working capital	ARS 3.2T
Working capital turnover	15,861.6

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3.68%
Dividend growth	26.28%
Dividend growth (10Y)	33.92%
Dividend growth (3Y)	164.76%
Dividend growth (5Y)	79.35%
Dividend growth years	3
Dividend payment date	2026-06-03
Dividend payment years	2
Dividend per share	ARS 274.47
Dividend yield	3.08%
Ex-dividend date	2026-05-13
Last dividend	ARS 274.47
Payout ratio	31.78%
Shareholder yield	-0.61%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	ARS 8,177.00
1D price change	2.41%
1M price change	8.13%
1M total return	8.13%
1W price change	3.14%
1W total return	3.14%
1Y price change	-3.17%
1Y return CAGR	0.39%
1Y total return	0.39%
20-day SMA	ARS 8,153.75
200-day SMA	ARS 8,347.95
3M price change	4.37%
3M total return	4.37%
3Y price change	180.03%
3Y return CAGR	44.31%
3Y total return	200.59%
50-day SMA	ARS 8,212.80
50-day SMA vs 200-day SMA	50under200
52-week high	ARS 9,810.00
52-week high date	2026-02-10
52-week low	ARS 7,495.00
52-week low date	2026-05-15
5Y price change	392.95%
5Y return CAGR	40%
5Y total return	437.65%
6M price change	6.02%
6M total return	9.92%
All-time high	ARS 9,810.00
All-time high date	2026-02-10
All-time low	ARS 667.37
All-time low date	2022-11-03
Average true range (ATR)	ARS 147.20
Average volume	1.2K
Change from 52-week high	-9.02%
Change from 52-week low	19.08%
Change from all-time high	-11.16%
Change from all-time low	1,205.86%
Change from open	0.11%
Day's gap	2.29%
Dollar volume	ARS 7.9M
High price	ARS 8,960.00
Low price	ARS 8,895.00
Monthly RSI	61.24
Open price	ARS 8,915.00
Position in 52-week range	46.15%
Previous close	ARS 8,715.00
Price vs 150-day SMA	6.58%
Price vs 20-day SMA	6.88%
Price vs 200-day SMA	4.4%
Price vs 50-day SMA	6.11%
Relative volume	0.76
RSI	66.56
Sharpe ratio	0.17
Sharpe ratio (3Y)	0.93
Sortino ratio	0.43
Sortino ratio (3Y)	1.53
Volume	881
Weekly RSI	56.84
YTD price change	4.56%
YTD total return	8.4%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	976.8M
Shares change (QoQ)	0%
Shares change (YoY)	3.68%
Shares held by insiders	0.06%
Shares held by institutions	59.85%

Deeper analysis on BCBA/PHG

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/PHG report

Is a complete BCBA/PHG research report available?

No complete published report is available for bcba/PHG (BCBA/PHG) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/PHG (BCBA/PHG)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/PHG

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/PHG indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/PHG

Frequently asked questions